SEC Form 4 · accession 0001179110-16-025276
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Bishop
Officer — Senior VP, Pharmaceutical Scie
Period of report
May 19, 2016
Accepted (ET)
May 23, 2016 · 12:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 19, 2016 | S | 397 | $10.20 | D | 157,640 | D | |
| Common Stock | May 19, 2016 | S | 387 | $10.20 | D | 157,253 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2009.